Forte Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Forte Biosciences

16/08/2021 15:52

* Forte Biosciences Inc  FBRX.OQ  reported a quarterly adjusted
loss of 43 cents​​ per share for the quarter ended in June. The
mean expectation of five analysts for the quarter was for a loss
of 43 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Forte Biosciences Inc's reported EPS for the quarter was a
loss of 43 cents​.
* The mean earnings estimate of analysts had fallen by
about 2.3% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Forte Biosciences Inc shares had fallen by 24.6% this
quarter and lost 30.4% so far this year.
* The company reported a quarterly loss of $5.81 million.
* Wall Street's median 12-month price target for Forte
Biosciences Inc is $90.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 16 at 02:52 p.m.  ​All
figures in US dollars unless otherwise stated